Should thrombolytic therapy be the first-line treatment for acute ischemic strokes?

New England Journal of Medicine

Volumn 337, Issue 18, 1997, Pages 1309-1310

  Caplan, L R ^a   Mohr, J P ^a   Kistler, J P ^a   Koroshetz, W ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NOTE; PRIORITY JOURNAL; STROKE; THROMBOSIS;

ACUTE DISEASE; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; HUMANS; PLASMINOGEN ACTIVATORS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0030778226     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199710303371812     Document Type: Note

References (7)